V1RF1 inhibitors are a distinct class of chemical compounds designed to modulate the activity of the V1RF1 protein. The V1RF1 protein is a key regulator in various cellular processes, and its proper function is crucial for maintaining cellular homeostasis. V1RF1 inhibitors work by specifically targeting and interacting with this protein to alter its activity. These inhibitors typically possess a range of chemical structures, each tailored to interact with specific binding sites or functional domains of the V1RF1 protein. The design of these inhibitors involves a detailed understanding of the protein's three-dimensional structure and the nature of its active sites, ensuring that the inhibitors bind selectively and effectively.
The chemical class of V1RF1 inhibitors encompasses various compounds with diverse structural motifs, including small molecules, peptides, or other chemical entities. These inhibitors are engineered to disrupt the normal function of V1RF1 by binding to critical sites involved in its biological activity. The interaction between the inhibitor and V1RF1 can lead to changes in the protein's conformation or disrupt its interactions with other molecules. This specific binding is often achieved through modifications to the inhibitor's functional groups or through the inclusion of certain structural features that enhance affinity and selectivity for V1RF1. The development of V1RF1 inhibitors involves sophisticated techniques in medicinal chemistry and structural biology to ensure that these compounds can effectively interact with the target protein while minimizing off-target effects.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gossypol | 303-45-7 | sc-200501 sc-200501A | 25 mg 100 mg | $114.00 $225.00 | 12 | |
Gossypol can inhibit gene expression by disrupting transcription factors or modulating signaling pathways. | ||||||
Ursolic Acid | 77-52-1 | sc-200383 sc-200383A | 50 mg 250 mg | $55.00 $176.00 | 8 | |
Ursolic acid has been reported to downregulate gene expression through interactions with transcriptional machinery. | ||||||
Cucurbitacin B | 6199-67-3 | sc-483515 | 5 mg | $183.00 | ||
Curcubitacin E may inhibit V1R234 expression by interfering with transcription factors or modulating signaling pathways. | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $57.00 $93.00 $240.00 $713.00 | 8 | |
Ellagic acid can modulate gene expression by affecting transcription factors or signaling cascades. | ||||||
Gambogic Acid | 2752-65-0 | sc-200137 sc-200137A sc-200137B sc-200137C sc-200137D | 5 mg 25 mg 100 mg 500 mg 1 g | $85.00 $243.00 $419.00 $720.00 $1230.00 | 5 | |
Gambogic acid has been shown to inhibit gene expression through interference with transcriptional machinery or signaling pathways. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide can inhibit gene expression through interactions with transcription factors or signaling pathways. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $79.00 $300.00 | 32 | |
Parthenolide has been reported to downregulate gene expression by interfering with transcriptional machinery. | ||||||
Andrographolide | 5508-58-7 | sc-205594 sc-205594A | 50 mg 100 mg | $15.00 $39.00 | 7 | |
Andrographolide may inhibit V1R234 expression by modulating transcription factors or signaling cascades. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $115.00 $337.00 | 3 | |
Betulinic acid can modulate gene expression through interactions with transcriptional regulators or signaling pathways. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $155.00 | 6 | |
Celastrol has been shown to inhibit gene expression by interfering with transcription factors or signaling cascades. | ||||||